1McLaughlin V V,Presberg K W,Doyle R L,Abman S H,McCrory D C,Fortin T, et al. Prognosis of pulmonary ayterial hypertension :ACCP evidence-based clinical practice guidelines[J].Chest, 2004,126 ( 1 Suppt) : 78S-92S.
3Tei C, Ling L H, Hodge D O, Bailey K R,Oh J K, Rodeheffer R J,et al. New index of combined systolic and diastolic myocardial performance:a simple and reproducible measure of cardiae function:a study in normals and dilated cardiomyopathy[J]. J Cardiol, 1995,26:357-366.
4Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension[J]. N Engl J Med, 2004,351 : 1425-1436.
9Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood vessels walls. N Engl J Med, 1979,300 (20) : 1142-1147.
10Christman BW, Mcpherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. New Engl J Med, 1992,327 (2) : 70-75.
3Xu Y,Stenmark KR,Das M,et al.Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetallike and acquire new growth properties.Am J Physiol,1997,273:L234-L245.
4Kim MR,Jeon ES,Kim YM,et al.Thromboxane a(2) induces differentiation of human mesenchymal stem cells to smooth musclelike cells.Stem Cells,2009,27:191-199.
5Je HD,Sohn UD.Inhibitory effect of genistein on agonist-induced modulation of vascular contractility.Mol Cells,2009,27:191-198.
6Anderson JR,Nawarskas JJ.Pharmacotherapeutic management of pulmonary arterial hypertension.Cardiol Rev,2010,18:148-162.
7McDonald JW,Ali M,Morgan E,et al.Thromboxane synthesis by sources other than platelets in association with complement induced pulmonary leukostasis and pulmonary hypertension in sheep.Circ Res,1983,52:1-6.
8Chlopicki S,Bartus JB,Gryglewski RJ.Hypoxic pulmonary vasoconstriction in isolated blood-perfused rat lung; modulation by thromboxane A2,platelet-activating factor,cysteinyl leukotrienes and endothelin-1.Pol J Pharmacol,2002,54:433-441.
9Fischer LG,Honemann CW,Pattie JT,et al.Ropivacaine attenuates pulmonary vasoconstriction induced by thromboxane A2 analogue in the isolated perfused rat lung.Reg Anesth Pain Med,2000,25:187-194.
10Sawhney N,Hall PA.Ki-67 structure,function,and new antibodies.J Pathol,1992,168:161-162.
